The change of intracellular pH is involved in the cisplatin-resistance of human lung adenocarcinoma A549/DDP cells

Cancer Investigation

Volumn 23, Issue 1, 2005, Pages 26-32

  Huang, Zhenhua ^a   Huang, Youguo ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

Author keywords

A549 DDP Cells; Cisplatin; MDR; pHi

Indexed keywords

ACRIDINE ORANGE; CARBON DIOXIDE; CISPLATIN; FLUORESCENT DYE; LIPOSOME;

ARTICLE; CANCER CELL CULTURE; CELL PH; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG RESISTANCE; ENCAPSULATION; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG ADENOCARCINOMA; PH MEASUREMENT; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

EID: 14844337867     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-46353     Document Type: Article

References (28)

1. Larsen, A.K.; Skladanowski, A. Cellular resistance to topoisomerase-targeted drugs: from drug uptake to cell death. Biochim. Biophys. Acta 1998, 1400, 257-274.
2. Loehrer, P.J.; Einhorn, L.H. Drugs five years later. Cisplatin. Ann. Intern. Med. 1984, 700, 704-713.
3. Timmer-Bosscha, H.; Mulder, N.H.; de Vries, E.G. Modulation of cis-diamminedichloroplatinum(II) resistance: a review. Br. J. Cancer 1992, 66, 227-238.
4. Andrews, P.A.; Velury, S.; Mann, S.C.; Howell, S.B. cis-Diamminedi- chloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res. 1988, 48, 68-73.
5. Bungo, M.; Fujiwara, Y.; Kasahara, K.; Nakagawa, K.; Ohe, Y.; Sasaki, Y.; Irino, S.; Saijo, N. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res. 1990, 50, 2549-2553.
6. Meijer, C.; Mulder, N.H.; Timmer-Bosscha, H.; Sluiter, W.J.; Meersma, G.J.; de Vries, E.G. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res. 1992, 52, 6885-6889.
7. Lai, G.M.; Ozols, R.F.; Smyth, J.F.; Young, R.C.; Hamilton, T.C. Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem. Pharmacol. 1988, 37, 4597-4600.
8. Masuda, H.; Ozols, R.F.; Lai, G.M.; Fojo, A.; Rothenberg, M.; Hamilton, T.C. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res. 1988, 48, 5713-5716.
9. Gottesman, M.M.; Pastan, I. The multidrug transporter, a double-edged sword. J. Biol. Chem. 1988, 263, 12163-12166.
10. Breuninger, L.M.; Paul, S.; Gaughan, K.; Miki, T.; Chan, A.; Aaronson, S.A.; Kruh, G.D. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 1995, 55, 5342-5347.
11. Cole, S.P.; Sparks, K.E.; Fraser, K.; Loe, D.W.; Grant, C.E.; Wilson, G.M.; Deeley, R.G. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res. 1994, 54, 5902-5910.
12. Koike, K.; Kawabe, T.; Tanaka, T.; Toh, S.; Uchiumi, T.; Wada, M.; Akiyama, S.; Ono, M.; Kuwano, M. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res. 1997, 57, 5475-5479.
13. Larsen, A.K.; Escarguil, A.E.; Andrzej, S. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol. Ther. 2000, 85, 217-229.
14. Simon, S.; Roy, D.; Schindler, M. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. 1994, 91, 1128-1132.
15. Castaing, M.; Loiseau, A.; Dani, M. Designing multidrug-resistance modulators circumventing the reverse pH gradient in tumours. J. Pharm. Pharmacol. 2001, 53, 1021-1028.
16. i are responsible for the anti-apoptosis character of A549/DDP cells. Prog. Biochem. Biophys. 2001, 28, 722-727.
17. Liang, X.; Huang, Y. Physical state changes of membrane lipids in human lung adenocarcinoma A549 cells and their resistance to cisplatin. Int. J. Biochem. Cell Biol. 2002, 34, 1248-1255.
18. Perez-Sala, D.; Collado-Escobart, D.; Mollinedo, F. Intracellular alkalinization suppresses lovastatin-induced apoptosis in HL-60 cells through the inactivation of a pH-dependent endonuclease. J. Biol. Chem. 1995, 270, 6235-6242.
19. Thomas, J.A.; Buchsbaum, R.N.; Zimniak, A.; Racker, E. Intracellular pH measurements in ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979, 18, 2210-2218.
20. + antiporter in suppression of apoptosis by granulocyte macrophage colony-stimulating factor and intrtleukin-3. J. Biol. Chem. 1992, 267, 9980-9987.
21. Melvin, S.; Sharon, G.; Hoff, E.; Simon, S.M. Defective pH regulation of acidic compartment in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7 adr). Biochemistry 1996, 35, 28111-28117.
22. Mayer, L.D.; Bally, M.B.; Cullis, P.R. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim. Biophys. Acta 1985, 816, 294-302.
23. Mayer, L.D.; Bally, M.B.; Hope, M.J.; Cullis. P.R. Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. J. Biol. Chem. 1985, 260, 802-808.
24. Rouser, G.; Fkeischer, S.; Yamamoto, A. Two dimensional then layer Chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 1970, 5, 494-496.
25. Nielsen, D.; Skovsgaard, T. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines. Biochim. Biophys. Acta 1992, 1139, 169-183.
26. Kruh, G.D.; Zeng, H.; Rea, P.A.; Liu, G.; Chen, Z.S.; Lee, K.; Belinsky, M.G. MRP subfamily transporters and resistance to anticancer agents. J. Bioenerg. Biomembranes 2001, 33, 493-501.
27. Akiyama, S.-i.; Chen, Z.-S.; Sumizawa, T.; Furukama, T. Resistance of cisplatin. Anti-Cancer Des. 1999, 14, 143-151.
28. Speelmans, G.; Sips, W.H.H.M.; Grisel, R.J.H.; Staffhorst, R.W.H.M.; Fichtinger-Schepman, A.M.J.; Reedijk, J.; Kruijff, B.de. The interaction of the anti-cancer drug cisplatin with phospholipids is specific negatively charged phospholipids and takes place at low chloride ion concentration. Biochim. Biophys. Acta 1996, 1238, 60-66.